- Home
- CTRN vs BNTC Comparison
CTRN vs BNTC Comparison
Compare CTRN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | BNTC |
|---|---|---|
| Founded | 1946 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.3M | 360.7M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CTRN | BNTC |
|---|---|---|
| Price | $48.12 | $11.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $52.00 | $27.67 |
| AVG Volume (30 Days) | ★ 123.2K | 63.1K |
| Earning Date | 06-02-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.14 | 80.94 |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $819,962,000.00 | N/A |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $8.35 | N/A |
| P/E Ratio | $72.48 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $28.45 | $9.85 |
| 52 Week High | $56.78 | $17.10 |
Technical Indicators
Market Signals| Indicator | CTRN | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 56.62 | 47.93 |
| Support Level | $42.06 | $10.05 |
| Resistance Level | $48.59 | $14.23 |
| Average True Range (ATR) | 4.04 | 0.60 |
| MACD | 0.36 | -0.01 |
| Stochastic Oscillator | 60.85 | 51.87 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.